Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Kelly

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancerCatherine M Kelly, Marjorie C Green, Kristine Broglio, et al.
Breast (Edinburgh, Scotland)|April 29, 2014
First international consensus guidelines for breast cancer in young women (BCY1)Ann H Partridge, Olivia Pagani, Omalkhair Abulkhair, et al.
JCO Precision Oncology|September 11, 2020
Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic AbnormalitiesSudipto Das, Deirdre Kelly, Bruce Moran, et al.
Breast Cancer Research and Treatment|September 14, 2015
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in IrelandLillian Smyth, Geoff Watson, Elaine M Walsh, et al.
Irish Journal of Medical Science|January 15, 2021
Virtual oncology clinics during the COVID-19 pandemicDavid O'Reilly, Hailey Carroll, Mairi Lucas, et al.
BMC Cancer|April 4, 2013
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancerPatrick C O Leary, Sarah A Penny, Roisin T Dolan, et al.
The Oncologist|June 21, 2024
Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapyDavid O'Reilly, Abdul Rehman Farooq, Paul Nevins Selvadurai, et al.
Cancers|July 26, 2020
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials IrelandCathriona Kearns, Ronan Feighery, John Mc Caffrey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 24, 2023
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPE<sup>B</sup> studyJosé Angel García-Sáenz, Frederik Marmé, Michael Untch, et al.
Nature Communications|June 23, 2026
Spatial analyses implicate high stromal tumour-infiltrating CD8<sup>+</sup> lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancerZak Kinsella, Chowdhury Arif Jahangir, Hannah Nyarkoah Nyarko, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancerCatherine M Kelly, Marjorie C Green, Kristine Broglio, et al.
Breast (Edinburgh, Scotland)|April 29, 2014
First international consensus guidelines for breast cancer in young women (BCY1)Ann H Partridge, Olivia Pagani, Omalkhair Abulkhair, et al.
JCO Precision Oncology|September 11, 2020
Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic AbnormalitiesSudipto Das, Deirdre Kelly, Bruce Moran, et al.
Breast Cancer Research and Treatment|September 14, 2015
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in IrelandLillian Smyth, Geoff Watson, Elaine M Walsh, et al.
Irish Journal of Medical Science|January 15, 2021
Virtual oncology clinics during the COVID-19 pandemicDavid O'Reilly, Hailey Carroll, Mairi Lucas, et al.
BMC Cancer|April 4, 2013
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancerPatrick C O Leary, Sarah A Penny, Roisin T Dolan, et al.
The Oncologist|June 21, 2024
Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapyDavid O'Reilly, Abdul Rehman Farooq, Paul Nevins Selvadurai, et al.
Cancers|July 26, 2020
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials IrelandCathriona Kearns, Ronan Feighery, John Mc Caffrey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 24, 2023
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPE<sup>B</sup> studyJosé Angel García-Sáenz, Frederik Marmé, Michael Untch, et al.
Nature Communications|June 23, 2026
Spatial analyses implicate high stromal tumour-infiltrating CD8<sup>+</sup> lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancerZak Kinsella, Chowdhury Arif Jahangir, Hannah Nyarkoah Nyarko, et al.
Pageof 7